3rd Quarter - Report — UCB, INC. for UCB, INC. (2022)

Firm

UCB, INC.

Client

UCB, INC.

Income

—

Expenses

$330,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 2163 - Safe Step Act H.R. 5376 - Inflation Reduction Act of 2022 H.R. 7667 - Food and Drug Amendments of 2022 H.R. 8931 - Improving Access to Safe Medicines Act of 2022 S. 464 - Safe Step Act S. 4348 - Food and Drug Administration Safety and Landmark Advancements Act of 2022

Lobbyist	Covered position, as disclosed
JED PERRY	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5376 (117th), H.R. 2163 (117th), S. 464 (117th), S. 4348 (117th), H.R. 8931 (117th), H.R. 7667 (117th)

Taxation/Internal Revenue Code TAX

H.R. 5376 - Inflation Reduction Act of 2022 S. 749 - American Innovation and Jobs Act

Lobbyist	Covered position, as disclosed
JED PERRY	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 749 (117th), H.R. 5376 (117th)

Insurance INS

H.R. 2163 - Safe Step Act S. 464 - Safe Step Act

Lobbyist	Covered position, as disclosed
JED PERRY	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 464 (117th), H.R. 2163 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.